- Update: There was also a detailed article on the topic in Boston STAT on March 13 here.
It's likely a firewall article, but NYT runs a detailed article on the growth of the field of FDA-approved digital therapeutics.
For example, one featured app is the ReSET app, prescription-only, which was authorized by the FDA last fall as the first app for improving outcomes in addiction treatment programs when used in conjunction with or added to outpatient standard of care.
The article discusses pro's, con's, and policy issues from a range of perspectives.
|click to enlarge|